Amphotericin B-copper(II) complex as a potential agent with higher antifungal activity against Candida albicans

European Journal of Pharmaceutical Sciences

Volumn 49, Issue 5, 2013, Pages 850-857

  Chudzik, Barbara ^a   Tracz, Izabela B ^a   Czernel, Grzegorz ^b   Fiołka, Marta J ^a   Borsuk, Grzegorz ^b   Gagoś, Mariusz ^a,b  

^a MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^b UNIVERSITY OF LIFE SCIENCES IN LUBLIN   (Poland)

Author keywords

Amphotericin B; Amphotericin B copper(II) complex; Antifungal activity; Candida albicans

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B COPPER; AMPHOTERICIN B DEOXYCHOLATE; COPPER COMPLEX; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA ALBICANS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SOLUBILITY; FUNGAL CELL; FUNGICIDAL ACTIVITY; INCUBATION TIME; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 84885078538     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.06.007     Document Type: Article

References (55)

1. Agarwal, A.K. et al., 2003. Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae. J. Biol. Chem. 278 (37), 34998-35015. (Pubitemid 37102261)
2. Babu, U., Failla, M.L., 1990. Respiratory burst and candidacidal activity of peritoneal macrophages are impaired in copper-deficient rats. J. Nutr. 120 (12), 1692-1699.
3. Baginski, M., Resat, H., Borowski, E., 2002. Comparative molecular dynamics simulations of amphotericin B-cholesterol/ergosterol membrane channels. Biochim. Biophys. Acta 1567 (1-2), 63-78. (Pubitemid 35454048)
4. Bagiński, M., Cybulska, B., Gruszecki, W.I., 2006. Interaction of polyene macrolide antibiotics with lipid model membranes. In: Ottova-Liu, A. (Ed.), Advances in Planar Lipid Bilayers and Liposomes. Elsevier Science Publ., Amsterdam, pp. 269-329. (Pubitemid 351970303)
5. Barwicz, J., Christian, S., Gruda, I., 1992. Effects of the aggregation state of amphotericin B on its toxicity to mice. Antimicrob. Agents Chemother. 36 (10), 2310-2315.
6. Beezer, A.E., Obrien, P., 1981. Complexes of polyene antibiotics with divalent metal-ions - complexes of Cu(II) with nystatin studied by visible circular-dichroism. J. Inorg. Nucl. Chem. 43 (7), 1669-1670.
7. Beezer, A.E., Obrien, P., Sham, W.L., 1985a. Stability-constants for, and structural investigation of divalent metal-ion complexes with polyene antibiotics. Inorg. Chim. Acta Bioinorg. Chem. 108 (2), 123-127.
8. Beezer, A.E., Obrien, P., Sham, W.L., 1985b. The synthesis and characterization of polyene complexes with divalent metal-ions - Mg(II), Ca(II), Ni(II), Cu(II) and Zn(II). Inorg. Chim. Acta Bioinorg. Chem. 108 (2), 117-122.
9. Belkherroubi-Sari, L. et al., 2008. Modulation of the polyene antibiotic amphotericin B selective toxicity by pH change of the stock solutions. Afr. J. Microbiol. Res. 2, 242-246.
10. + efflux in the activation of apoptosis. J. Biol. Chem. 272 (51), 32436-32442. (Pubitemid 28011927)
11. Brajtburg, J., Bolard, J., 1996. Carrier effects on biological activity of amphotericin B. Clin. Microbiol. Rev. 9 (4), 512-531. (Pubitemid 26366536)
12. 4 donor macrocyclic ligands. Trans. Met. Chem. 29, 269-275.
13. Chandra, S., Tyagi, M., Sharma, K., 2009. Mn(II), Co(II), Ni(II) and Cu(II) complexes of a tertraaza macrocyclic ligand: synthesis, characterization and biological screening. J. Iran. Chem. Soc. 6 (2), 310-316.
14. 2+ of amphotericin B induced lysis of erythrocytes. FEBS Lett. 178 (1), 127-131. (Pubitemid 15216600)
15. Chiou, S.-H., 1983. DNA-and protein-scission activities of ascorbate in the presence of copper ion and a copper-peptide complex. J. Biochem. 94, 1259-1267.
16. Clemons, K.V., Stevens, D.A., 2004. Comparative efficacies of four amphotericin B formulations-Fungizone, amphotec (Amphocil), Am Bisome, and Abelcet-against systemic murine aspergillosis. Antimicrob. Agents Chemother. 48 (3), 1047-1050. (Pubitemid 38280367)
17. Cotero, B.V., Rebolledo-Antunez, S., Ortega-Blake, I., 1998. On the role of sterol in the formation of the amphotericin B channel. Biochim. Biophys. Acta 1375, 43-51. (Pubitemid 28514428)
18. De Kruijff, B. et al., 1974. Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes. I. Specificity of the membrane permeability changes induced by the polyene antibiotics. Biochim. Biophys. Acta 339 (1), 30-43.
19. Dollwet, H.H.A., Sorenson, J.R.J., 1985. Historic uses of copper compounds in medicine. Trace Elem. Med. 2 (2), 80-87. (Pubitemid 15061540)
20. Ellis, D., 2002. Amphotericin B: spectrum and resistance. J. Antimicrob. Chemother. 49, 7-10. (Pubitemid 34162651)
21. Flannagan, R.S., Cosio, G., Grinstein, S., 2009. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat. Rev. Microbiol. 7 (5), 355-366.
22. Forbes, J.R., Gros, P., 2001. Divalent-metal transport by NRAMP proteins at the interface of host-pathogen interactions. Trends Microbiol. 9 (8), 397-403. (Pubitemid 32763067)
23. Gabrielska, J. et al., 2006. Binding of antibiotic amphotericin B to lipid membranes: a 1H NMR study. FEBS Lett. 580 (11), 2677-2685.
24. Gagoś, M. et al., 2005. Binding of antibiotic amphotericin B to lipid membranes: monomolecular layer technique and linear dichroism-FTIR studies. Mol. Membr. Biol. 22 (5), 433-442. (Pubitemid 41747105)
25. Gagoś, M. et al., 2008. Anomalously high aggregation level of the polyene antibiotic amphotericin B in acidic medium: implications for the biological action. Biophys. Chem. 136 (1), 44-49.
26. +) complexes. Biometals.
27. Goldstein, S., Czapski, G., 1990. Transition metal ions and oxygen radicals. Int. Rev. Exp. Pathol. 31, 133-164.
28. Hann, I.M., Prentice, H.G., 2001. Lipid-based amphotericin B: a review of the last 10 years of use. Int. J. Antimicrob. Ag. 17, 161-169. (Pubitemid 32229893)
29. Hartsel, S., Bolard, J., 1996. Amphotericin B: new life for an old drug. Trends Pharmacol. Sci. 17 (12), 445-449. (Pubitemid 27028476)
30. Herec, M. et al., 2005. An effect of antibiotic amphotericin B on ion transport across model lipid membranes and tonoplast membranes. Biochem. Pharmacol. 70 (5), 668-675. (Pubitemid 41058701)
31. Hoshino, N. et al., 1999. Damage to the cytoplasmic membrane of E. coli by catechin-copper(II) complexes. Free Rad. Biol. Med. 27, 1245-1250. (Pubitemid 30001485)
32. Hoshino, N. et al., 2000. Bactericidal activity of catechin-copper(II) complexes against Staphylococcus aureus compared with Escherichia coli. Lett. Appl. Microbiol. 31 (3), 213-217.
33. Hsu, S., Burnette, R., 1997. Charakterization of the effect of amphotericin B on ion channels in MDCK cells using the patch-clamp technique. Biochim. Biophys. Acta 1329, 26-38. (Pubitemid 27464800)
34. Inselmann, G., Inselmann, U., Heidemann, H.T., 2002. Amphotericin B and liver function. Eur. J. Int. Med. 13 (5), 288-292. (Pubitemid 34812339)
35. Jones, D.G., Suttle, N.F., 1981. Some effects of copper deficiency on leucocyte function in sheep and cattle. Res. Vet. Sci. 31 (2), 151-156. (Pubitemid 12240631)
36. Kadiiska, M.B., Mason, R.P., 2002. In vivo copper-mediated free radical production: an ESR spin-trapping study. Spectrochim. Acta A Mol. Biomol. Spectrosc. 58 (6), 1227-1239. (Pubitemid 34222662)
37. Lemke, A., Kiderlen, A.F., Kayser, O., 2005. Amphotericin B. Appl. Microbiol. Biotechnol. 68 (2), 151-162. (Pubitemid 41110936)
38. -)-cotransport blocker bumetanide. Life Sci. 66 (23), PL319-324. (Pubitemid 30256631)
39. Martin, E. et al., 1994. Novel aspect of amphotericin B action: accumulation in human monocytes potentiates killing of phagocytosed Candida albicans. Antimicrob. Agents Chemother. 38 (1), 13-22. (Pubitemid 24018151)
40. Mehta, R.T. et al., 1994. Phagocyte transport as mechanism for enhanced therapeutic activity of liposomal amphotericin B. Chemotherapy 40 (4), 256-264. (Pubitemid 24163036)
41. NCCLS, 2002. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast; Approved Standard-Second edition. NCCLS document M27-A2 [ISBN 1-56238-469-4]. NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA.
42. Ogita, A. et al., 2010. Dependence of vacuole disruption and independence of potassium ion efflux in fungicidal activity induced by combination of amphotericin B and allicin against Saccharomyces cerevisiae. J. Antibiot. (Tokyo) 63 (12), 689-692.
43. Ohashi, K. et al., 2003. Copper(II) protects yeast against the toxicity of cisplatin independently of the induction of metallothionein and the inhibition of platinum uptake. Biochem. Biophys. Res. Commun. 310, 148-152. (Pubitemid 37162775)
44. Petit, C. et al., 1999. Activity of a heat-induced reformulation of amphotericin B deoxycholate (fungizone) against Leishmania donovani. Antimicrob. Agents Chemother. 43 (2), 390-392. (Pubitemid 29079181)
45. Rao, M.R., Olinde, K.D., Markov, A.K., 1997. Protection from amphotericin B-induced lipid peroxidation in rats by fructose-1,6-diphosphate. Res. Commun. Mol. Pathol. Pharmacol. 95 (2), 217-220. (Pubitemid 27147565)
46. Rees, E.M., Thiele, D.J., 2004. From aging to virulence: forging connections through the study of copper homeostasis in eukaryotic microorganisms. Curr. Opin. Microbiol. 7, 175-184. (Pubitemid 38447052)
47. Sakunthala, M., Subramanian, P., 2012. Synthesis, characterization and antimicrobial studies of Cu(II), Ni(II), Mn(II) and Zn(II) Schiff base complexes derived from 2-hydroxy naphthaldehyde and 1,8-diaminonaphthalene. Int. J. Pharm. Technol. 4 (3), 4630-4644.
48. Samanovic, M.I. et al., 2012. Copper in microbial pathogenesis: meddling with the metal. Cell Host Microbe. 11 (2), 106-115.
49. Singh, D. et al., 2010. Template synthesis and characterization of biologically active transition metal complexes comprising 14-membered tetraazamacrocyclic ligand. J. Serb. Chem. Soc. 75 (2), 217-228.
50. Smith, P.J. et al., 2007. Effects of dosing regimen on accumulation, retention and prophylactic efficacy of liposomal amphotericin B. J. Antimicrob. Chemother. 59 (5), 941-951. (Pubitemid 47073366)
51. Te Dorsthorst, D.T.A. et al., 2004. Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates. Antimicrob. Agents Chemother. 48 (8), 3147-3150. (Pubitemid 38989190)
52. Vertut-Croquin, A. et al., 1983. Differences in the interaction of the polyene antibiotic amphotericin B with cholesterol-or ergosterol-containing phospholipid vesicles. A circual dichroism and permeability study. Biochemistry 22, 2939-2944.
53. Wolschendorf, F. et al., 2011. Copper resistance is essential for virulence of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 108, 1621-1626.
54. Zhang, L. et al., 2002. Response of gene expression in Saccharomyces cerevisiae to amphotericin B and nystatin measured by microarrays. J. Antimicrob. Chemother. 49, 905-915. (Pubitemid 34692884)
55. Zotchev, S.B., 2003. Polyene macrolide antibiotics and their applications in human therapy. Curr. Med. Chem. 10 (3), 211-223. (Pubitemid 36131654)